Advertisement

Topics

Allergan says revenue from aesthetics unit may double by 2025

07:56 EDT 14 Sep 2018 | Reuters

Allergan Plc said revenue from its medical aesthetics business could double by 2025, even as it faces increasing competition for its blockbuster wrinkle treatment, Botox.

Original Article: Allergan says revenue from aesthetics unit may double by 2025

NEXT ARTICLE

More From BioPortfolio on "Allergan says revenue from aesthetics unit may double by 2025"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...